|
||||||||||||
 |
||||||||||||
|
||||||||||||
Top Stories
Vaccine Information Statements
Featured Resources
Notable Publications
Global News
Upcoming Events
Top Stories
“Ask the Experts: Hepatitis B” web page updated with new recommendation for universal vaccination of adults through age 59 and added information about PreHevbrio vaccine
Immunize.org updated its popular Ask the Experts: Hepatitis B web page. This extensive list of clinical questions and answers incorporates the new recommendation for universal vaccination of adults through age 59 and adds information about PreHevbrio (manufactured by VBI). PreHevbrio is licensed and recommended as a hepatitis B vaccine option for people age 18 and older. It is administered as a 3-dose series.
Back to top
CDC will convene its Advisory Committee on Immunization Practices (ACIP) today, April 20, from 11:00 a.m.–4:00 p.m. (ET).
National Infant Immunization Week (NIIW), April 24–30, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. This year, it’s particularly critical to ensure that families get back on track for routine checkups and recommended vaccinations following disruptions from the COVID-19 pandemic.
Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,282 organizations, including six new hospitals, one long-term care facility, and a large outpatient clinic network
Immunize.org's Influenza Vaccination Honor Roll recognizes facilities that take a stand for patient safety by implementing policies for mandatory healthcare personnel influenza vaccination. There are now 1,282 healthcare organizations enrolled. Since December 8, 2021, six new hospitals, one long-term care facility, and a large network of outpatient medical practices have been added to the honor roll.
 Eligibility:
Influenza Surveillance
In this week's Spotlight, we summarize resources at Immunize.org that focus on specific vaccine products. These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Vaccine Information Statements
Reminder! Haitian Creole and Portuguese translations of 18 Vaccine Information Statements posted by Immunize.org.
Immunize.org posted new translations of 18 Vaccine Information Statements (VISs) in Haitian Creole and Portuguese. These translations were generously donated by the Massachusetts Department of Public Health Immunization Program.
VIS translations in Portuguese:
Translations of previous VIS versions may be used until new translations become available. CDC states that the corresponding up-to-date English-language VIS must also be supplied when providing an out-of-date translation.
Featured Resources
CHOP’s Vaccine Education Center releases “Communicating about Vaccines – COVID-19 and More,” a free, web-based interactive module; CE available
Children’s Hospital of Philadelphia’s (CHOP) Vaccine Education Center (VEC) released Communicating about Vaccines – COVID-19 and More, a free, web-based interactive session. It is divided into three parts:
To access versions “for credit” (registration required) or “no credit,” visit Online Learning for Healthcare Providers web page. Immunize.org's laminated versions of the 2022 U.S. child and adolescent immunization schedule and the 2022 U.S. adult immunization schedule are in stock and shipping now. Order while supplies last.
PRICING
For quotes on customizing or placing orders of 1,000 copies or more, call 651-647-9009 or email [email protected].
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination, to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide).
Notable Publications
“Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022” published in MMWR
CDC published Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization among Adults with Previous SARS-CoV-2 Infection—United States, June 2021–February 2022 in MMWR. A portion of the summary appears below. Persons with previous SARS-CoV-2 infection have some protection against reinfection leading to hospitalization, but there is limited evidence regarding the additional benefit of vaccination among these persons.... Among persons with previous infection, COVID-19 mRNA vaccination provided protection against subsequent COVID-19–associated hospitalization. Estimated vaccine effectiveness against reinfection leading to hospitalization during the Omicron-predominant period was approximately 35% after dose 2, and 68% after a booster dose.... To prevent COVID-19–associated hospitalization, all eligible persons should stay up to date with vaccination, including those with previous SARS-CoV-2 infection.
Back to top
“Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders” published in Vaccine In its March 28 issue, Vaccine published Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders. The article is a collaborative effort of the Association of Immunization Managers, with lead author Katelyn Wells, MS, PhD, Immunize.org's Kelly L. Moore, MD, MPH, and Emory University’s Robert Bednarczyk, PhD. The conclusion appears below. The 64 state, local and territorial IPs [immunization programs] are the backbone of the US immunization system, so we advocate for engagement of all stakeholders to directly support IPs in addressing vaccine hesitancy within their jurisdictions. To maintain routine vaccination coverage rates and implement a successful COVID-19 vaccination campaign, IPs need engagement of stakeholders at all levels to promote sound immunization policies, identify and address the needs of vulnerable subpopulations, implement evidence-based strategies to promote the value of vaccination, and combat misinformation online. IPs, with support of stakeholders, are the key to effectively addressing the complex challenges of vaccine hesitancy in order to bring the pandemic to a swift end. Back to top
"Become a Vaccine Champion" published by American Federation of Teachers The American Federation of Teachers published Become a Vaccine Champion, written by Immunize.org’s Mary Beth Koslap-Petraco, DNP, FAANP. A portion of the article appears below. By virtue of our profession, nurses have a head start in championing vaccines for ourselves, our patients, and our communities. Ours is the most trusted of all professions. We are rated highly because we’re seen as honest and ethical. The public trusts that we put our patients’ needs ahead of the interests of others. Our voices are heard and our opinions are respected because of what we do. No matter what field of nursing we practice, we all spend much of our time educating patients. We have a way of speaking that makes complicated material understandable without talking down to patients. We need to use that influence to clarify misinformation about vaccines, reassure each other and the public that the science behind vaccines is solid, and encourage everyone to get vaccinated. I truly believe that every nurse should be a vaccine champion and that every nurse can be a vaccine champion. It all starts with conversations with fellow nurses who may be hesitant about vaccines. Global News CDC published Surveillance to Track Progress toward Polio Eradication—Worldwide, 2020–2021 on April 15 in MMWR. A portion of the summary appears below. Acute flaccid paralysis (AFP) surveillance, the primary means of tracking poliovirus transmission, is supplemented by environmental surveillance of sewage samples. The COVID-19 pandemic negatively affected polio surveillance.... Analysis of 2020–2021 AFP surveillance data from 43 priority countries experiencing or at high risk for poliovirus transmission found that national AFP surveillance performance improved from 2020 to 2021 in many priority countries, particularly in the World Health Organization’s African Region; however, substantial national and subnational gaps persist.... Surveillance gaps need to be identified and addressed to ensure timely detection of poliovirus circulation and achieve eventual eradication.
“One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer” published by WHO The World Health Organization (WHO) published One-Dose Human Papillomavirus (HPV) Vaccine Offers Solid Protection against Cervical Cancer on April 11. The recommendations of WHO do not alter the ACIP-recommended schedule for HPV vaccination in the United States. The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the two or three-dose regimens. SAGE’s review concluded that a single-dose Human Papillomavirus (HPV) vaccine delivers solid protection against HPV, the virus that causes cervical cancer, that is comparable to 2-dose schedules. This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls.... “The HPV vaccine is highly effective for the prevention of HPV serotypes 16 & 18, which cause 70% of cervical cancer,” said Dr Alejandro Cravioto, SAGE Chair. “SAGE urges all countries to introduce HPV vaccines and prioritize multi-age cohort catch up of missed and older cohorts of girls. These recommendations will enable more girls and women to be vaccinated and thus preventing them from having cervical cancer and all its consequences over the course of their lifetimes.” SAGE recommended one- or two-dose vaccination schedules for girls and women through age 20 and two doses for women 21 and older. WHO’s recommendations will be updated following further consultation across stakeholders. Related Links
Upcoming Events
Tomorrow! Virtual: Immunize Colorado hosts webinar “For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence” on April 21. Immunize Colorado will host a webinar with IDEO.org and National Resource Center for Refugees, Immigrants, and Migrants (NRC-RIM) titled For Mothers, by Mothers: A Community Health Meetup That Supports Vaccine Confidence at 12:00 p.m. (ET) on April 21. The webinar showcases the Mothers X Mothers initiative, a toolkit designed to help organizations implement health-focused meetups for immigrant and refugee moms. There will also be focus on how organizations can support vaccine confidence in any community. Register for the webinar. Virtual: International Vaccine Access Center hosts webinars on April 26, 28, and May 3 for World Immunization Week Johns Hopkins University's International Vaccine Access Center (IVAC), along with global immunization and indigenous health partners, will host a series of three webinars to recognize World Immunization Week, April 24 to 30. Registration dates and times are as follows:
In person: Register today! National Conference for Immunization Coalitions and Partnerships to be held September 13–15, 2022, in Minneapolis, MN.
Immunize.org and Voices for Vaccines are cosponsoring the 15th National for Immunization Coalitions and Partnerships (NCICP). This is planned as an in-person meeting in Minneapolis/St. Paul at the Radisson Blu Mall of America on September 13–15, 2022. Register for the event. Registration fee: $300 (early bird $260 registration available now). For more upcoming events, visit our Calendar of Events.
|
||||||||||||
|
